Trehalose, an mTOR Independent Autophagy Inducer, Alleviates Human Podocyte Injury after Puromycin Aminonucleoside Treatment

Autophagy and apoptosis: where do they meet?

(2014) Subhadip Mukhopadhyay et al.   APOPTOSIS

Proteomics analysis of autophagy-deficient Atg7−/− MEFs reveals a close relationship between F-actin and autophagy

(2013) Cuiqin Zhuo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The cytoprotective role of autophagy in puromycin aminonucleoside treated human podocytes

(2013) Yu-Lin Kang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury

(2013) Lingling Wu et al.   PLoS One

mTOR Signaling in Autophagy Regulation in the Kidney

(2013) Ken Inoki   SEMINARS IN NEPHROLOGY

Autophagy: Emerging Therapeutic Target for Diabetic Nephropathy

(2013) Shinji Kume et al.   SEMINARS IN NEPHROLOGY

Autophagy in Glomerular Health and Disease

(2013) Björn Hartleben et al.   SEMINARS IN NEPHROLOGY

Guidelines for the use and interpretation of assays for monitoring autophagy

(2012) Daniel J. Klionsky et al.   Autophagy

Mammalian target of rapamycin signaling in the podocyte

(2012) Ken Inoki et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile

(2012) Tarak Srivastava et al.   Journal of Cell Communication and Signaling

Trehalose: Current Use and Future Applications

(2011) Satoshi Ohtake et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease

(2011) Alan S. L. Wong et al.   NATURE CELL BIOLOGY

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

(2011) Joungmok Kim et al.   NATURE CELL BIOLOGY

The podocyte cytoskeleton—key to a functioning glomerulus in health and disease

(2011) Gavin I. Welsh et al.   Nature Reviews Nephrology

The podocyte as a target for therapies—new and old

(2011) Peter W. Mathieson   Nature Reviews Nephrology

Autophagic degradation of tau in primary neurons and its enhancement by trehalose

(2011) Ulrike Krüger et al.   NEUROBIOLOGY OF AGING

ANG II promotes autophagy in podocytes

(2010) Anju Yadav et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Autophagic degradation of active caspase-8

(2010) Wen Hou et al.   Autophagy

Methods in Mammalian Autophagy Research

(2010) Noboru Mizushima et al.   CELL

Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease

(2010) B. R. Underwood et al.   HUMAN MOLECULAR GENETICS

Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice

(2010) Björn Hartleben et al.   JOURNAL OF CLINICAL INVESTIGATION

mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression

(2010) Tobias B. Huber et al.   KIDNEY INTERNATIONAL

Autophagy and the degradation of mitochondria

(2010) Scott J. Goldman et al.   MITOCHONDRION

Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies

(2008) S Sarkar et al.   CELL DEATH AND DIFFERENTIATION

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis

(2008) Jeroen K.J. Deegens et al.   KIDNEY INTERNATIONAL

Novel targets for Huntington's disease in an mTOR-independent autophagy pathway

(2008) Andrea Williams et al.   Nature Chemical Biology